Edge Rewrite
everything Source code View original
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a23cc6850edd5cd4

Jump to content

David Flockhart

Add links
From Wikipedia, the free encyclopedia
Image of David A. Flockhart

David A. Flockhart (1952–2015) was a Scottish medical researcher who was a leader in the field of personalised medicine.[1] He was especially known for his work on factors affecting the use of tamoxifen to treat breast cancer such as variability in the level of the CYP2D6 enzyme.[2][3]

References

[edit]
  1. ↑ "In death, there is life", The Economist, p. 84, 26 March 2016
  2. ↑ "David Flockhart : Obituary", Edinburgh Evening News, 3 December 2015
  3. ↑ In Memoriam, David A. Flockhart PhD, MD, Indiana University Department of Medicine, 26 November 2015
Retrieved from "https://en.wikipedia.org/w/index.php?title=David_Flockhart&oldid=1361524236"